PM Kisan 21st Installment Live Updates: The wait for the PM Kisan Samman Nidhi’s 21st installment is now going to be over today, after Prime Minister Narendra Modi is set to release the next tranche of Rs 2,000 shortly at an event in Coimbatore, Tamil Nadu.

“The prime minister will release the 21st installment of PM-KISAN on November 19, 2025, in Coimbatore, Tamil Nadu,” according to PM Kisan’s portal.

As per the government data, Rs 18,000 crore will be transferred to nearly 9 crore farmers nationwide. Combined with state schemes, many farmers are receiving additional income buffers ahead of the agri season.

“This instalment comes at a crucial moment: rising input costs, mandi price volatility, and liquidity gaps continue to challenge small and marginal farmers. A deeper lens on how direct benefit transfers are influencing farm decisions, post-harvest management, storage choices, and credit dependency could make for a compelling industry story,” said Amith Agarwal, co-founder and CEO of StarAgri Warehousing & Collateral Management.

PM Kisan: How To Check Beneficiary Status?

1. Visit the official PM Kisan portal: https://pmkisan.gov.in

2. On the homepage, under the ‘FARMERS CORNER’, click on ‘Beneficiary List’.

3. Enter your state, district, sub-district, block, and village.

4. Click ‘Get Report’ to view the list of beneficiaries in your village.

Jefferies has initiated its coverage of WeWork India with a buy rating and a target price of Rs 790. Analysts said that the company is the largest flexible workspace operator by revenues in India. At about 17% compounded annual growth rate (CAGR), flexible workspace stock is growing at two times the pace of office stock, with room for further penetration. They said WeWork’s premium positioning helps command higher average revenue per member and margins than peers.Motilal Oswal Securities has initiated its coverage of PB Fintech with a neutral rating and a target price of Rs 2,000. Analysts expect PB Fintech to post a strong FY25-FY28 revenue, earnings before interest, taxes, depreciation, and amortisation (EBITDA) and profit after tax (PAT) CAGR of 35%, 156% and 56%, respectively, after factoring in a strengthening position in under-penetrated credit and insurance industries. However, they believe the stock is fairly valued, and all positives are priced in at current levels. Any possibility of commission restructuring by insurance companies due to the loss of input tax credit post GST exemption poses a key risk for the company’s top-line growth.Morgan Stanley has an overweight rating on Eternal (formerly Zomato) with the target price at Rs 427. They believe Eternal has the best risk-reward matrix and investors would use the current weakness to accumulate the stock. Like Eternal’s strategy of doubling down on customer market share as wallet share expansion can follow later. Theyassume a stress case of higher aggression could mean push out of profitability but this is not a game changer. They are assuming a stress case scenario where the stock would bottom out at Rs 280 – Rs 285.UBS has a buy rating on Max Healthcare Institute with the target price at Rs 1,550. Analysts expect the company’s brownfield capacity addition to drive growth and earnings. The management said that it recently commissioned a Mohali facility including an oncology facility. It’s also commissioning a facility at Nanavati hospital inMumbai.Also the construction activity at other new hospitals is progressing well. The management indicated that the issues related to cashless service for insurance patients has been resolved and mentioned there was no/only limited impact as patients shift from insurance to cash in such instances.Nomura has a neutral rating on Oil India with the target price at Rs 430. Analysts said the company’s July-Sept quarter was a soft one as volumes were impacted by external factors. The expansion work at Numaligarh Refinery was on track, with first crude intake expected next month and a meaningful volume uptick by the July-Sept quarter ofnext year. Analysts cut Oil India’s FY26 and FY27 profit estimates by 37% and 18%, respectively, to reflect: Lower gas sales volume, lower crude price realizations, higher depletion & depreciation expenses, and sharply higher exploratory write-offs and impairments.